The exponential rise in the adoption of self-injection devices for the treatment of autoimmune disorders has created a buzz among companies to invest in the development of novel autoimmune disorder drug delivery devices. Due to the leading market products and intense market penetration, Amgen Inc. has been a pioneer in this field and has been a significant competitor in this market.

The global market for Autoimmune Disorder Drug Delivery Device was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Autoimmune Disorder Drug Delivery Device, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Autoimmune Disorder Drug Delivery Device by region & country, by Type, and by Application.

The Autoimmune Disorder Drug Delivery Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autoimmune Disorder Drug Delivery Device.

Market Segmentation

Scope of Autoimmune Disorder Drug Delivery Device - Market Report

Report Metric	Details
Report Name	Autoimmune Disorder Drug Delivery Device - Market
CAGR	5%
Segment by Type:	Pen Injectors Auto-Injectors Prefilled Syringes Vials
Segment by Application	In-house Manufacturing Outsourced Manufacturing
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie Inc., Amgen Inc., F. Hoffmann- La Roche Ltd., Novartis AG, GlaxoSmithKline Plc, Biogen Inc., Merck KGaA, Bayer AG, Johnson & Johnson Services Inc., Teva Pharmaceutical Industries Ltd., Eli Lily and Company, Sanofi S.A., Takeda Pharmaceutical Company Limited
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Autoimmune Disorder Drug Delivery Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Autoimmune Disorder Drug Delivery Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Autoimmune Disorder Drug Delivery Device in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Autoimmune Disorder Drug Delivery Device - Market report?

Ans: The main players in the Autoimmune Disorder Drug Delivery Device - Market are AbbVie Inc., Amgen Inc., F. Hoffmann- La Roche Ltd., Novartis AG, GlaxoSmithKline Plc, Biogen Inc., Merck KGaA, Bayer AG, Johnson & Johnson Services Inc., Teva Pharmaceutical Industries Ltd., Eli Lily and Company, Sanofi S.A., Takeda Pharmaceutical Company Limited

What are the Application segmentation covered in the Autoimmune Disorder Drug Delivery Device - Market report?

Ans: The Applications covered in the Autoimmune Disorder Drug Delivery Device - Market report are In-house Manufacturing, Outsourced Manufacturing

What are the Type segmentation covered in the Autoimmune Disorder Drug Delivery Device - Market report?

Ans: The Types covered in the Autoimmune Disorder Drug Delivery Device - Market report are Pen Injectors, Auto-Injectors, Prefilled Syringes, Vials

1 Market Overview

1.1 Autoimmune Disorder Drug Delivery Device Product Introduction

1.2 Global Autoimmune Disorder Drug Delivery Device Market Size Forecast

1.2.1 Global Autoimmune Disorder Drug Delivery Device Sales Value (2019-2030)

1.2.2 Global Autoimmune Disorder Drug Delivery Device Sales Volume (2019-2030)

1.2.3 Global Autoimmune Disorder Drug Delivery Device Sales Price (2019-2030)

1.3 Autoimmune Disorder Drug Delivery Device Market Trends & Drivers

1.3.1 Autoimmune Disorder Drug Delivery Device Industry Trends

1.3.2 Autoimmune Disorder Drug Delivery Device Market Drivers & Opportunity

1.3.3 Autoimmune Disorder Drug Delivery Device Market Challenges

1.3.4 Autoimmune Disorder Drug Delivery Device Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Autoimmune Disorder Drug Delivery Device Players Revenue Ranking (2023)

2.2 Global Autoimmune Disorder Drug Delivery Device Revenue by Company (2019-2024)

2.3 Global Autoimmune Disorder Drug Delivery Device Players Sales Volume Ranking (2023)

2.4 Global Autoimmune Disorder Drug Delivery Device Sales Volume by Company Players (2019-2024)

2.5 Global Autoimmune Disorder Drug Delivery Device Average Price by Company (2019-2024)

2.6 Key Manufacturers Autoimmune Disorder Drug Delivery Device Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Autoimmune Disorder Drug Delivery Device Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Autoimmune Disorder Drug Delivery Device

2.9 Autoimmune Disorder Drug Delivery Device Market Competitive Analysis

2.9.1 Autoimmune Disorder Drug Delivery Device Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Autoimmune Disorder Drug Delivery Device Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Disorder Drug Delivery Device as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Pen Injectors

3.1.2 Auto-Injectors

3.1.3 Prefilled Syringes

3.1.4 Vials

3.2 Global Autoimmune Disorder Drug Delivery Device Sales Value by Type

3.2.1 Global Autoimmune Disorder Drug Delivery Device Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Autoimmune Disorder Drug Delivery Device Sales Value, by Type (2019-2030)

3.2.3 Global Autoimmune Disorder Drug Delivery Device Sales Value, by Type (%) (2019-2030)

3.3 Global Autoimmune Disorder Drug Delivery Device Sales Volume by Type

3.3.1 Global Autoimmune Disorder Drug Delivery Device Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Autoimmune Disorder Drug Delivery Device Sales Volume, by Type (2019-2030)

3.3.3 Global Autoimmune Disorder Drug Delivery Device Sales Volume, by Type (%) (2019-2030)

3.4 Global Autoimmune Disorder Drug Delivery Device Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 In-house Manufacturing

4.1.2 Outsourced Manufacturing

4.2 Global Autoimmune Disorder Drug Delivery Device Sales Value by Application

4.2.1 Global Autoimmune Disorder Drug Delivery Device Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Autoimmune Disorder Drug Delivery Device Sales Value, by Application (2019-2030)

4.2.3 Global Autoimmune Disorder Drug Delivery Device Sales Value, by Application (%) (2019-2030)

4.3 Global Autoimmune Disorder Drug Delivery Device Sales Volume by Application

4.3.1 Global Autoimmune Disorder Drug Delivery Device Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Autoimmune Disorder Drug Delivery Device Sales Volume, by Application (2019-2030)

4.3.3 Global Autoimmune Disorder Drug Delivery Device Sales Volume, by Application (%) (2019-2030)

4.4 Global Autoimmune Disorder Drug Delivery Device Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Autoimmune Disorder Drug Delivery Device Sales Value by Region

5.1.1 Global Autoimmune Disorder Drug Delivery Device Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Autoimmune Disorder Drug Delivery Device Sales Value by Region (2019-2024)

5.1.3 Global Autoimmune Disorder Drug Delivery Device Sales Value by Region (2025-2030)

5.1.4 Global Autoimmune Disorder Drug Delivery Device Sales Value by Region (%), (2019-2030)

5.2 Global Autoimmune Disorder Drug Delivery Device Sales Volume by Region

5.2.1 Global Autoimmune Disorder Drug Delivery Device Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Autoimmune Disorder Drug Delivery Device Sales Volume by Region (2019-2024)

5.2.3 Global Autoimmune Disorder Drug Delivery Device Sales Volume by Region (2025-2030)

5.2.4 Global Autoimmune Disorder Drug Delivery Device Sales Volume by Region (%), (2019-2030)

5.3 Global Autoimmune Disorder Drug Delivery Device Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Autoimmune Disorder Drug Delivery Device Sales Value, 2019-2030

5.4.2 North America Autoimmune Disorder Drug Delivery Device Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Autoimmune Disorder Drug Delivery Device Sales Value, 2019-2030

5.5.2 Europe Autoimmune Disorder Drug Delivery Device Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Autoimmune Disorder Drug Delivery Device Sales Value, 2019-2030

5.6.2 Asia Pacific Autoimmune Disorder Drug Delivery Device Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Autoimmune Disorder Drug Delivery Device Sales Value, 2019-2030

5.7.2 South America Autoimmune Disorder Drug Delivery Device Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales Value, 2019-2030

5.8.2 Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Autoimmune Disorder Drug Delivery Device Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Autoimmune Disorder Drug Delivery Device Sales Value

6.2.1 Key Countries/Regions Autoimmune Disorder Drug Delivery Device Sales Value, 2019-2030

6.2.2 Key Countries/Regions Autoimmune Disorder Drug Delivery Device Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Autoimmune Disorder Drug Delivery Device Sales Value, 2019-2030

6.3.2 United States Autoimmune Disorder Drug Delivery Device Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Autoimmune Disorder Drug Delivery Device Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Autoimmune Disorder Drug Delivery Device Sales Value, 2019-2030

6.4.2 Europe Autoimmune Disorder Drug Delivery Device Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Autoimmune Disorder Drug Delivery Device Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Autoimmune Disorder Drug Delivery Device Sales Value, 2019-2030

6.5.2 China Autoimmune Disorder Drug Delivery Device Sales Value by Type (%), 2023 VS 2030

6.5.3 China Autoimmune Disorder Drug Delivery Device Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Autoimmune Disorder Drug Delivery Device Sales Value, 2019-2030

6.6.2 Japan Autoimmune Disorder Drug Delivery Device Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Autoimmune Disorder Drug Delivery Device Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Autoimmune Disorder Drug Delivery Device Sales Value, 2019-2030

6.7.2 South Korea Autoimmune Disorder Drug Delivery Device Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Autoimmune Disorder Drug Delivery Device Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Autoimmune Disorder Drug Delivery Device Sales Value, 2019-2030

6.8.2 Southeast Asia Autoimmune Disorder Drug Delivery Device Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Autoimmune Disorder Drug Delivery Device Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Autoimmune Disorder Drug Delivery Device Sales Value, 2019-2030

6.9.2 India Autoimmune Disorder Drug Delivery Device Sales Value by Type (%), 2023 VS 2030

6.9.3 India Autoimmune Disorder Drug Delivery Device Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 AbbVie Inc.

7.1.1 AbbVie Inc. Company Information

7.1.2 AbbVie Inc. Introduction and Business Overview

7.1.3 AbbVie Inc. Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)

7.1.4 AbbVie Inc. Autoimmune Disorder Drug Delivery Device Product Offerings

7.1.5 AbbVie Inc. Recent Development

7.2 Amgen Inc.

7.2.1 Amgen Inc. Company Information

7.2.2 Amgen Inc. Introduction and Business Overview

7.2.3 Amgen Inc. Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Amgen Inc. Autoimmune Disorder Drug Delivery Device Product Offerings

7.2.5 Amgen Inc. Recent Development

7.3 F. Hoffmann- La Roche Ltd.

7.3.1 F. Hoffmann- La Roche Ltd. Company Information

7.3.2 F. Hoffmann- La Roche Ltd. Introduction and Business Overview

7.3.3 F. Hoffmann- La Roche Ltd. Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)

7.3.4 F. Hoffmann- La Roche Ltd. Autoimmune Disorder Drug Delivery Device Product Offerings

7.3.5 F. Hoffmann- La Roche Ltd. Recent Development

7.4 Novartis AG

7.4.1 Novartis AG Company Information

7.4.2 Novartis AG Introduction and Business Overview

7.4.3 Novartis AG Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Novartis AG Autoimmune Disorder Drug Delivery Device Product Offerings

7.4.5 Novartis AG Recent Development

7.5 GlaxoSmithKline Plc

7.5.1 GlaxoSmithKline Plc Company Information

7.5.2 GlaxoSmithKline Plc Introduction and Business Overview

7.5.3 GlaxoSmithKline Plc Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)

7.5.4 GlaxoSmithKline Plc Autoimmune Disorder Drug Delivery Device Product Offerings

7.5.5 GlaxoSmithKline Plc Recent Development

7.6 Biogen Inc.

7.6.1 Biogen Inc. Company Information

7.6.2 Biogen Inc. Introduction and Business Overview

7.6.3 Biogen Inc. Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Biogen Inc. Autoimmune Disorder Drug Delivery Device Product Offerings

7.6.5 Biogen Inc. Recent Development

7.7 Merck KGaA

7.7.1 Merck KGaA Company Information

7.7.2 Merck KGaA Introduction and Business Overview

7.7.3 Merck KGaA Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Merck KGaA Autoimmune Disorder Drug Delivery Device Product Offerings

7.7.5 Merck KGaA Recent Development

7.8 Bayer AG

7.8.1 Bayer AG Company Information

7.8.2 Bayer AG Introduction and Business Overview

7.8.3 Bayer AG Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Bayer AG Autoimmune Disorder Drug Delivery Device Product Offerings

7.8.5 Bayer AG Recent Development

7.9 Johnson & Johnson Services Inc.

7.9.1 Johnson & Johnson Services Inc. Company Information

7.9.2 Johnson & Johnson Services Inc. Introduction and Business Overview

7.9.3 Johnson & Johnson Services Inc. Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Johnson & Johnson Services Inc. Autoimmune Disorder Drug Delivery Device Product Offerings

7.9.5 Johnson & Johnson Services Inc. Recent Development

7.10 Teva Pharmaceutical Industries Ltd.

7.10.1 Teva Pharmaceutical Industries Ltd. Company Information

7.10.2 Teva Pharmaceutical Industries Ltd. Introduction and Business Overview

7.10.3 Teva Pharmaceutical Industries Ltd. Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Teva Pharmaceutical Industries Ltd. Autoimmune Disorder Drug Delivery Device Product Offerings

7.10.5 Teva Pharmaceutical Industries Ltd. Recent Development

7.11 Eli Lily and Company

7.11.1 Eli Lily and Company Company Information

7.11.2 Eli Lily and Company Introduction and Business Overview

7.11.3 Eli Lily and Company Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Eli Lily and Company Autoimmune Disorder Drug Delivery Device Product Offerings

7.11.5 Eli Lily and Company Recent Development

7.12 Sanofi S.A.

7.12.1 Sanofi S.A. Company Information

7.12.2 Sanofi S.A. Introduction and Business Overview

7.12.3 Sanofi S.A. Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Sanofi S.A. Autoimmune Disorder Drug Delivery Device Product Offerings

7.12.5 Sanofi S.A. Recent Development

7.13 Takeda Pharmaceutical Company Limited

7.13.1 Takeda Pharmaceutical Company Limited Company Information

7.13.2 Takeda Pharmaceutical Company Limited Introduction and Business Overview

7.13.3 Takeda Pharmaceutical Company Limited Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)

7.13.4 Takeda Pharmaceutical Company Limited Autoimmune Disorder Drug Delivery Device Product Offerings

7.13.5 Takeda Pharmaceutical Company Limited Recent Development

8 Industry Chain Analysis

8.1 Autoimmune Disorder Drug Delivery Device Industrial Chain

8.2 Autoimmune Disorder Drug Delivery Device Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Autoimmune Disorder Drug Delivery Device Sales Model

8.5.2 Sales Channel

8.5.3 Autoimmune Disorder Drug Delivery Device Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

AbbVie

Amgen Inc

F Hoffmann La Roche Ltd

Johnson & Johnson Services Inc.

Teva Pharmaceutical Industries Ltd

Eli Lily And Company

Sanofi

Takeda Pharmaceutical Company Limited

List of Tables

Table 1. Autoimmune Disorder Drug Delivery Device Market Trends

Table 2. Autoimmune Disorder Drug Delivery Device Market Drivers & Opportunity

Table 3. Autoimmune Disorder Drug Delivery Device Market Challenges

Table 4. Autoimmune Disorder Drug Delivery Device Market Restraints

Table 5. Global Autoimmune Disorder Drug Delivery Device Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Company (2019-2024)

Table 7. Global Autoimmune Disorder Drug Delivery Device Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Autoimmune Disorder Drug Delivery Device Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Autoimmune Disorder Drug Delivery Device Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Autoimmune Disorder Drug Delivery Device Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Autoimmune Disorder Drug Delivery Device Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Autoimmune Disorder Drug Delivery Device

Table 13. Global Autoimmune Disorder Drug Delivery Device Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Disorder Drug Delivery Device as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Autoimmune Disorder Drug Delivery Device Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Autoimmune Disorder Drug Delivery Device Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Autoimmune Disorder Drug Delivery Device Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Autoimmune Disorder Drug Delivery Device Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Autoimmune Disorder Drug Delivery Device Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Autoimmune Disorder Drug Delivery Device Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Autoimmune Disorder Drug Delivery Device Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Autoimmune Disorder Drug Delivery Device Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Autoimmune Disorder Drug Delivery Device Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Autoimmune Disorder Drug Delivery Device Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Autoimmune Disorder Drug Delivery Device Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Autoimmune Disorder Drug Delivery Device Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Autoimmune Disorder Drug Delivery Device Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Autoimmune Disorder Drug Delivery Device Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Autoimmune Disorder Drug Delivery Device Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Autoimmune Disorder Drug Delivery Device Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Autoimmune Disorder Drug Delivery Device Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Autoimmune Disorder Drug Delivery Device Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Autoimmune Disorder Drug Delivery Device Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Autoimmune Disorder Drug Delivery Device Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Autoimmune Disorder Drug Delivery Device Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Autoimmune Disorder Drug Delivery Device Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Autoimmune Disorder Drug Delivery Device Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Autoimmune Disorder Drug Delivery Device Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Autoimmune Disorder Drug Delivery Device Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Autoimmune Disorder Drug Delivery Device Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Autoimmune Disorder Drug Delivery Device Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Autoimmune Disorder Drug Delivery Device Sales Value by Region (2019-2024) & (%)

Table 44. Global Autoimmune Disorder Drug Delivery Device Sales Value by Region (2025-2030) & (%)

Table 45. Global Autoimmune Disorder Drug Delivery Device Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Autoimmune Disorder Drug Delivery Device Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Autoimmune Disorder Drug Delivery Device Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Autoimmune Disorder Drug Delivery Device Sales Volume by Region (2019-2024) & (%)

Table 49. Global Autoimmune Disorder Drug Delivery Device Sales Volume by Region (2025-2030) & (%)

Table 50. Global Autoimmune Disorder Drug Delivery Device Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Autoimmune Disorder Drug Delivery Device Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Autoimmune Disorder Drug Delivery Device Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Autoimmune Disorder Drug Delivery Device Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Autoimmune Disorder Drug Delivery Device Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Autoimmune Disorder Drug Delivery Device Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Autoimmune Disorder Drug Delivery Device Sales Volume, (2025-2030) & (K Units)

Table 57. AbbVie Inc. Company Information

Table 58. AbbVie Inc. Introduction and Business Overview

Table 59. AbbVie Inc. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. AbbVie Inc. Autoimmune Disorder Drug Delivery Device Product Offerings

Table 61. AbbVie Inc. Recent Development

Table 62. Amgen Inc. Company Information

Table 63. Amgen Inc. Introduction and Business Overview

Table 64. Amgen Inc. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Amgen Inc. Autoimmune Disorder Drug Delivery Device Product Offerings

Table 66. Amgen Inc. Recent Development

Table 67. F. Hoffmann- La Roche Ltd. Company Information

Table 68. F. Hoffmann- La Roche Ltd. Introduction and Business Overview

Table 69. F. Hoffmann- La Roche Ltd. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. F. Hoffmann- La Roche Ltd. Autoimmune Disorder Drug Delivery Device Product Offerings

Table 71. F. Hoffmann- La Roche Ltd. Recent Development

Table 72. Novartis AG Company Information

Table 73. Novartis AG Introduction and Business Overview

Table 74. Novartis AG Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Novartis AG Autoimmune Disorder Drug Delivery Device Product Offerings

Table 76. Novartis AG Recent Development

Table 77. GlaxoSmithKline Plc Company Information

Table 78. GlaxoSmithKline Plc Introduction and Business Overview

Table 79. GlaxoSmithKline Plc Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. GlaxoSmithKline Plc Autoimmune Disorder Drug Delivery Device Product Offerings

Table 81. GlaxoSmithKline Plc Recent Development

Table 82. Biogen Inc. Company Information

Table 83. Biogen Inc. Introduction and Business Overview

Table 84. Biogen Inc. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Biogen Inc. Autoimmune Disorder Drug Delivery Device Product Offerings

Table 86. Biogen Inc. Recent Development

Table 87. Merck KGaA Company Information

Table 88. Merck KGaA Introduction and Business Overview

Table 89. Merck KGaA Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Merck KGaA Autoimmune Disorder Drug Delivery Device Product Offerings

Table 91. Merck KGaA Recent Development

Table 92. Bayer AG Company Information

Table 93. Bayer AG Introduction and Business Overview

Table 94. Bayer AG Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Bayer AG Autoimmune Disorder Drug Delivery Device Product Offerings

Table 96. Bayer AG Recent Development

Table 97. Johnson & Johnson Services Inc. Company Information

Table 98. Johnson & Johnson Services Inc. Introduction and Business Overview

Table 99. Johnson & Johnson Services Inc. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. Johnson & Johnson Services Inc. Autoimmune Disorder Drug Delivery Device Product Offerings

Table 101. Johnson & Johnson Services Inc. Recent Development

Table 102. Teva Pharmaceutical Industries Ltd. Company Information

Table 103. Teva Pharmaceutical Industries Ltd. Introduction and Business Overview

Table 104. Teva Pharmaceutical Industries Ltd. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. Teva Pharmaceutical Industries Ltd. Autoimmune Disorder Drug Delivery Device Product Offerings

Table 106. Teva Pharmaceutical Industries Ltd. Recent Development

Table 107. Eli Lily and Company Company Information

Table 108. Eli Lily and Company Introduction and Business Overview

Table 109. Eli Lily and Company Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. Eli Lily and Company Autoimmune Disorder Drug Delivery Device Product Offerings

Table 111. Eli Lily and Company Recent Development

Table 112. Sanofi S.A. Company Information

Table 113. Sanofi S.A. Introduction and Business Overview

Table 114. Sanofi S.A. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. Sanofi S.A. Autoimmune Disorder Drug Delivery Device Product Offerings

Table 116. Sanofi S.A. Recent Development

Table 117. Takeda Pharmaceutical Company Limited Company Information

Table 118. Takeda Pharmaceutical Company Limited Introduction and Business Overview

Table 119. Takeda Pharmaceutical Company Limited Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 120. Takeda Pharmaceutical Company Limited Autoimmune Disorder Drug Delivery Device Product Offerings

Table 121. Takeda Pharmaceutical Company Limited Recent Development

Table 122. Key Raw Materials Lists

Table 123. Raw Materials Key Suppliers Lists

Table 124. Autoimmune Disorder Drug Delivery Device Downstream Customers

Table 125. Autoimmune Disorder Drug Delivery Device Distributors List

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

List of Figures

Figure 1. Autoimmune Disorder Drug Delivery Device Product Picture

Figure 2. Global Autoimmune Disorder Drug Delivery Device Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Autoimmune Disorder Drug Delivery Device Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Autoimmune Disorder Drug Delivery Device Sales Volume (2019-2030) & (K Units)

Figure 5. Global Autoimmune Disorder Drug Delivery Device Sales Price (2019-2030) & (US$/Unit)

Figure 6. Autoimmune Disorder Drug Delivery Device Report Years Considered

Figure 7. Global Autoimmune Disorder Drug Delivery Device Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Autoimmune Disorder Drug Delivery Device Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Autoimmune Disorder Drug Delivery Device Revenue in 2023

Figure 10. Autoimmune Disorder Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Pen Injectors Picture

Figure 12. Auto-Injectors Picture

Figure 13. Prefilled Syringes Picture

Figure 14. Vials Picture

Figure 15. Global Autoimmune Disorder Drug Delivery Device Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 16. Global Autoimmune Disorder Drug Delivery Device Sales Value Market Share by Type, 2023 & 2030

Figure 17. Global Autoimmune Disorder Drug Delivery Device Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 18. Global Autoimmune Disorder Drug Delivery Device Sales Volume Market Share by Type, 2023 & 2030

Figure 19. Global Autoimmune Disorder Drug Delivery Device Price by Type (2019-2030) & (US$/Unit)

Figure 20. Product Picture of In-house Manufacturing

Figure 21. Product Picture of Outsourced Manufacturing

Figure 22. Global Autoimmune Disorder Drug Delivery Device Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 23. Global Autoimmune Disorder Drug Delivery Device Sales Value Market Share by Application, 2023 & 2030

Figure 24. Global Autoimmune Disorder Drug Delivery Device Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 25. Global Autoimmune Disorder Drug Delivery Device Sales Volume Market Share by Application, 2023 & 2030

Figure 26. Global Autoimmune Disorder Drug Delivery Device Price by Application (2019-2030) & (US$/Unit)

Figure 27. North America Autoimmune Disorder Drug Delivery Device Sales Value (2019-2030) & (US$ Million)

Figure 28. North America Autoimmune Disorder Drug Delivery Device Sales Value by Country (%), 2023 VS 2030

Figure 29. Europe Autoimmune Disorder Drug Delivery Device Sales Value (2019-2030) & (US$ Million)

Figure 30. Europe Autoimmune Disorder Drug Delivery Device Sales Value by Country (%), 2023 VS 2030

Figure 31. Asia Pacific Autoimmune Disorder Drug Delivery Device Sales Value (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Autoimmune Disorder Drug Delivery Device Sales Value by Country (%), 2023 VS 2030

Figure 33. South America Autoimmune Disorder Drug Delivery Device Sales Value (2019-2030) & (US$ Million)

Figure 34. South America Autoimmune Disorder Drug Delivery Device Sales Value by Country (%), 2023 VS 2030

Figure 35. Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales Value (2019-2030) & (US$ Million)

Figure 36. Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales Value by Country (%), 2023 VS 2030

Figure 37. Key Countries/Regions Autoimmune Disorder Drug Delivery Device Sales Value (%), (2019-2030)

Figure 38. Key Countries/Regions Autoimmune Disorder Drug Delivery Device Sales Volume (%), (2019-2030)

Figure 39. United States Autoimmune Disorder Drug Delivery Device Sales Value, (2019-2030) & (US$ Million)

Figure 40. United States Autoimmune Disorder Drug Delivery Device Sales Value by Type (%), 2023 VS 2030

Figure 41. United States Autoimmune Disorder Drug Delivery Device Sales Value by Application (%), 2023 VS 2030

Figure 42. Europe Autoimmune Disorder Drug Delivery Device Sales Value, (2019-2030) & (US$ Million)

Figure 43. Europe Autoimmune Disorder Drug Delivery Device Sales Value by Type (%), 2023 VS 2030

Figure 44. Europe Autoimmune Disorder Drug Delivery Device Sales Value by Application (%), 2023 VS 2030

Figure 45. China Autoimmune Disorder Drug Delivery Device Sales Value, (2019-2030) & (US$ Million)

Figure 46. China Autoimmune Disorder Drug Delivery Device Sales Value by Type (%), 2023 VS 2030

Figure 47. China Autoimmune Disorder Drug Delivery Device Sales Value by Application (%), 2023 VS 2030

Figure 48. Japan Autoimmune Disorder Drug Delivery Device Sales Value, (2019-2030) & (US$ Million)

Figure 49. Japan Autoimmune Disorder Drug Delivery Device Sales Value by Type (%), 2023 VS 2030

Figure 50. Japan Autoimmune Disorder Drug Delivery Device Sales Value by Application (%), 2023 VS 2030

Figure 51. South Korea Autoimmune Disorder Drug Delivery Device Sales Value, (2019-2030) & (US$ Million)

Figure 52. South Korea Autoimmune Disorder Drug Delivery Device Sales Value by Type (%), 2023 VS 2030

Figure 53. South Korea Autoimmune Disorder Drug Delivery Device Sales Value by Application (%), 2023 VS 2030

Figure 54. Southeast Asia Autoimmune Disorder Drug Delivery Device Sales Value, (2019-2030) & (US$ Million)

Figure 55. Southeast Asia Autoimmune Disorder Drug Delivery Device Sales Value by Type (%), 2023 VS 2030

Figure 56. Southeast Asia Autoimmune Disorder Drug Delivery Device Sales Value by Application (%), 2023 VS 2030

Figure 57. India Autoimmune Disorder Drug Delivery Device Sales Value, (2019-2030) & (US$ Million)

Figure 58. India Autoimmune Disorder Drug Delivery Device Sales Value by Type (%), 2023 VS 2030

Figure 59. India Autoimmune Disorder Drug Delivery Device Sales Value by Application (%), 2023 VS 2030

Figure 60. Autoimmune Disorder Drug Delivery Device Industrial Chain

Figure 61. Autoimmune Disorder Drug Delivery Device Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions